Department of Psychiatry

Kyle M. Kampman

Associate Professor of Psychiatry at the Veteran's Administration Medical Center

Department: Psychiatry

Contact information

University of Pennsylvania
Treatment Research Center
3900 Chestnut Street
Philadelphia, PA 19104

Office: (215) 222-3200

Email:
kampman_k@mail.trc.upenn.edu

Education
B.A. (Chemistry)
Northwestern University, 1981.
M.D (?)
Tulane University, 1985.

Permanent link

SOM » Psychiatry Home » Faculty Database

Selected Publications

Kampman, K.M., Volpicelli, J.R., Mulvaney, F., Rukstalis, M., Alterman, A.I., Pettinati, H., Weinrieb, R.M., O'Brien, C.P.: Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addictive Behaviors 27(2): 251-260, 2002.

Kampman, K.M.: Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms. Expert Review of Neurotherapeutics 2(5): 601-608, 2002.

Kampman, K.M., Pettinati, H., Volpicelli, J., Kaempf, G., Turk, E., Insua, A., Lipkin, C., Sparkman, T., O'Brien, C.P.: Concurrent cocaine withdrawal alters alcohol withdrawal symptoms. Journal of Addictive Diseases 21(4): 13-26, 2002.

Kampman, K.M., Majewska, M.D., Tourian, K., Dackis, C., Cornish, J., Poole, S., O’Brien, C.P.: A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addictive Behaviors 28: 437-448, 2002.

Dackis, C., Kampman, K., Pettinati, H, Weigley, C., O’Brien, C.: An Open-Label Pilot Study of the Effectiveness and Tolerability of Modafinil for Cocaine Dependence. Drug and Alcohol Dependence 66(suppl1): s39-s40, 2002.

Yu, E., Herman, B.H., Miotto, K., Montgomery, A., Fudala, P.J., Chiang, C.J., Fisher, C., Kampman, K., Dhopesh, V., Cornish, J., Walsh, B., Davies, K., Vocci, F., Bridge, P., Ling, W., O’Brien, C.P.: An In-patient Phase I/II Study of Lofexidine (alpha-2 adrenergic agonist) for Opiate Detoxification. Drug and Alcohol Dependence 66(suppl1): s195, 2002.

Kampman, K.M., Alterman, A.I., Volpicelli, J.R., Maany, I., Muller, E.S., Luce, D.L., Mulholland, E.M., Jawad, A.F., Parikh, G.A., Mulvaney, F.D., Weinrieb, R.M., O’Brien, C.P.: Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychology of Addictive Behaviors 15(1): 52-59, 2001.

Kampman, K.M., Volpicelli, J.R., Mulvaney, F., Alterman, A.I., Cornish, J., Gariti, P. Cnaan, A., Poole, S., Muller, E., Acosta, T., Luce, D., O'Brien, C.P.: Effectiveness of propranolol for cocaine dependence may depend on cocaine withdrawal symptom severity. Drug and Alcohol Dependence 63(1): 69-78, 2001.

Kampman KM., Dackis C., Lynch KG., Pettinati H., Tirado C., Gariti P., Sparkman T., Atzram M., O'Brien CP.: A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug & Alcohol Dependence 85(2): 129-37, Nov 8 2006.

Dackis., C., Lynch, K., Yu, E., Samaha, F., Kampman, K., Cornish, J., Rowan, A., Poole, S., White, L., O’Brien, C.: Modafinil and Cocaine: A Double-Blind, Placebo-Controlled Drug Interaction Study. Drug and Alcohol Dependence 70(1): 29-37, 2003.

Comer SD., Sullivan MA., Yu E., Rothenberg JL., Kleber HD., Kampman K., Dackis C., O'Brien CP.: Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Archives of General Psychiatry 63(2): 210-8, Feb 2006.